Cargando...

Dengue vaccine development: status and future

Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decades of research, the first dengue vaccine was licensed in 2015: CYD-TDV, a tetravalent live attenuated vaccine with a yellow fever vaccine backbone. Recent analys...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Autor principal: Wilder-Smith, Annelies
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7224137/
https://ncbi.nlm.nih.gov/pubmed/31784763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00103-019-03060-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!